Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy

Keyphrases

• Autophagy 100%
• Vaccine Adjuvant 100%
• Adjuvant Activity 100%
• Synthetic Glycolipid 100%
• TLR4 100%
• RAW264.7 Cells 40%
• Toll-like 40%
• Antigen Processing 40%
• Bone Marrow-derived Macrophages 40%
• Macrophages 20%
• Interleukin-2 20%
• Immunization 20%
• Receptor-mediated 20%
• Monocytes 20%
• Activated T Cells 20%
• NF-B 20%
• Adaptive Immunity 20%
• Immune Response 20%
• Antigen-presenting Cells 20%
• Antigen-specific Immune Response 20%
• Antigen Presentation 20%
• Innate Immunity 20%
• RB Pathway 20%
• Autophagy Inhibitor 20%
• Antigen-specific 20%
• Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 20%
• 3-methyladenine (3-MA) 20%
• Peritoneal Cavity 20%
• Beclin-1 20%
• Antigen-specific Response 20%
• Serum Biochemical Profile 20%
• Antigen-specific CD4 T Cells 20%
• Immune Adjuvant 20%
• Processing Activities 20%
• Host Immune Defense 20%
• Autophagy-related 20%
• Specific IgE 20%

Immunology and Microbiology

• TLR4 100%
• Autophagy 100%
• Vaccine Adjuvant 100%
• Glycolipid 100%
• Antigen Specificity 57%
• Antigen Presentation 42%
• Adjuvant 28%
• Immune Response 28%
• Bone Marrow-Derived Macrophage 28%
• Toll-Like Receptor 28%
• Macrophage 14%
• T Cell 14%
• Innate Immune System 14%
• Monocyte 14%
• Cytokine 14%
• Adaptive Immune System 14%
• Interleukin 2 14%
• T-Helper Cell 14%
• Transcription Factor Nrf2 14%
• Peritoneal Cavity 14%
• Antigen Presenting Cell 14%